fbpx
30.8 C
Kuala Lumpur
Friday, January 28, 2022
HomeNewsKKM lodges police report against Dr Musa's baseless Vaccine Procurement Corruption

KKM lodges police report against Dr Musa’s baseless Vaccine Procurement Corruption

The Ministry of Health (KKM) said that they will be lodging a police report against the allegations of corruption in the procurement of the Moderna Covid-19 vaccine raised by consultant paediatrician Dr Musa Nordin.

According to Sinar Harian, KKM denied Musa’s allegations that the Special Committee on COVID-19 Vaccine Supply (JKJAV) did not made orders for the Moderna vaccine, and the National Pharmaceutical Regulatory Agency (NPRA) did not register the vaccine, as there were “not enough kickbacks”.

Responding to the allegations, KKM said that the discussions for the procurement of Moderna type vaccine were held with its manufacturer ModernaTX Inc at the end of 2020.

KKM added that ModernaTX Inc had on 6 December 2020 offered vaccines that is sufficient to vaccinate 10% of the Malaysian population and will begin the delivery in the 3rd and 4th quarter of 2021.

However, JKJAV had decided that the procurement should be made with other manufacturers who could supply Covid-19 vaccines earlier as this is crucial to speed up the implementation of the National Covid-19 Immunisation Programme.

Meanwhile, KKM said that ModernaTX had only submitted registration to the National Pharmaceutical Regulatory Agency (NPRA) in July this year through its appointed company.

Meanwhile, KKM also views that these allegations seriously and will lodge a police report regarding the matter.

According to The Edge, KKM was also reported to said that the government will decide on the need for the Moderna vaccine after the vaccine was approved for registration by the NPRA, including its use as a shot or through heterology.

“The government already has a portfolio and a sufficient number of doses to vaccinate the population of Malaysia.” KKM said.

Meanwhile, the 362nd Drug Control Authority (DCA) Meeting today approved conditional registration for use during an emergency situation of the Spikevax 0.20 mg/ml Dispersion for Injection Covid-19 mRNA Vaccine (nucleoside modified) product from product registration holder (PRH) Zuellig Pharma Sdn Bhd, and manufacturer Rovi Pharma Industrial Services, Spain.

The Spikevax product is also known as the Covid-19 Moderna vaccine.

Watch the interview with Dr Musa Nordin here:

Leave a reply

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments